Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy L Oleinick

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 14, 2016
Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamineNancy L Oleinick, Tithi Biswas, Rutulkumar Patel, et al.
The Laryngoscope|January 22, 2010
Photodynamic therapy of cottontail rabbit papillomavirus-induced papillomas in a severe combined immunodeficient mouse xenograft systemRichard G Lee, Mark A Vecchiotti, John Heaphy, et al.
Photochemistry and Photobiology|April 28, 2011
Photodynamic therapy with Pc 4 induces apoptosis of Candida albicansMinh Lam, Paul C Jou, Ali A Lattif, et al.
Advances in Hematology|January 4, 2011
Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndromeMinh Lam, Yoojin Lee, Min Deng, et al.
Lasers in Surgery and Medicine|January 20, 2011
Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trialElma D Baron, Christi L Malbasa, Diana Santo-Domingo, et al.
Frontiers in Oncology|June 1, 2012
Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancersTimothy James Kinsella, Elma D Baron, Valdir C Colussi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed-Platinum-Radiation in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: Results of a Phase I TrialTithi Biswas, Afshin Dowlati, Charles A Kunos, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Potent competitive inhibition of human ribonucleotide reductase by a nonnucleoside small moleculeMd Faiz Ahmad, Intekhab Alam, Sarah E Huff, et al.
Journal of Medicinal Chemistry|October 22, 2015
Identification of Non-nucleoside Human Ribonucleotide Reductase ModulatorsMd Faiz Ahmad, Sarah E Huff, John Pink, et al.
Photochemistry and Photobiology|January 29, 2008
Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4Malcolm S Ke, Liang-yan Xue, Denise K Feyes, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 14, 2016
Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamineNancy L Oleinick, Tithi Biswas, Rutulkumar Patel, et al.
The Laryngoscope|January 22, 2010
Photodynamic therapy of cottontail rabbit papillomavirus-induced papillomas in a severe combined immunodeficient mouse xenograft systemRichard G Lee, Mark A Vecchiotti, John Heaphy, et al.
Photochemistry and Photobiology|April 28, 2011
Photodynamic therapy with Pc 4 induces apoptosis of Candida albicansMinh Lam, Paul C Jou, Ali A Lattif, et al.
Advances in Hematology|January 4, 2011
Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndromeMinh Lam, Yoojin Lee, Min Deng, et al.
Lasers in Surgery and Medicine|January 20, 2011
Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trialElma D Baron, Christi L Malbasa, Diana Santo-Domingo, et al.
Frontiers in Oncology|June 1, 2012
Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancersTimothy James Kinsella, Elma D Baron, Valdir C Colussi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed-Platinum-Radiation in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: Results of a Phase I TrialTithi Biswas, Afshin Dowlati, Charles A Kunos, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Potent competitive inhibition of human ribonucleotide reductase by a nonnucleoside small moleculeMd Faiz Ahmad, Intekhab Alam, Sarah E Huff, et al.
Journal of Medicinal Chemistry|October 22, 2015
Identification of Non-nucleoside Human Ribonucleotide Reductase ModulatorsMd Faiz Ahmad, Sarah E Huff, John Pink, et al.
Photochemistry and Photobiology|January 29, 2008
Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4Malcolm S Ke, Liang-yan Xue, Denise K Feyes, et al.
Pageof 6